QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inovio-pharmaceuticals-form-13g-shows-deep-track-capital-lp-reported-a-999-stake-in-the-co-as-of-april-16-2024

- SEC Filing

 why-skillsoft-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Skillsoft Corp. (NASDAQ: SKIL) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter...

 inovio-pharmaceuticals-stock-is-diving-today-whats-happening

Inovio announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering price of $7.693...

 why-macatawa-bank-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Shares of Macatawa Bank Corporation (NASDAQ: MCBC) rose sharply in today’s pre-market trading after Wintrust Financial Corpora...

 live-nation-entertainment-groupon-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were mixed this morning, with the Dow futures gaining around 100 points on Tuesday.

 reported-earlier-inovio-prices-36m-underwritten-offering-of-2536258-common-stock-at-7693share

INOVIO Pharmaceuticals announced the pricing of an underwritten offering of 2,536,258 shares of its common stock at an offering...

Core News & Articles

https://twitter.com/DrTedros/status/1778423967105139108  

 oppenheimer-maintains-outperform-on-inovio-pharmaceuticals-maintains-40-price-target

Oppenheimer analyst Hartaj Singh maintains Inovio Pharmaceuticals (NASDAQ:INO) with a Outperform and maintains $40 price tar...

 rbc-capital-reiterates-sector-perform-on-inovio-pharmaceuticals-maintains-11-price-target

RBC Capital analyst Gregory Renza reiterates Inovio Pharmaceuticals (NASDAQ:INO) with a Sector Perform and maintains $11 pri...

 victorias-secret-inovio-pharmaceuticals-broadcom-aptorum-group-tesla-why-these-5-stocks-are-on-investors-radars-today

Wednesday: Dow up 0.2% at 38,661.05, S&P 500 up 0.5% to 5,104.76, Nasdaq up 0.6% at 16,031.54.

 inovio-pharmaceuticals-q4-2023-gaap-eps-1100-beats-1270-estimate-sales-103000k-miss-344200k-estimate

Inovio Pharmaceuticals (NASDAQ:INO) reported quarterly losses of $(1.100) per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-march-6-2024

Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $0.14 per share on revenue o...

 oppenheimer-upgrades-inovio-pharmaceuticals-to-outperform-announces-4-price-target

Oppenheimer analyst Hartaj Singh upgrades Inovio Pharmaceuticals (NASDAQ:INO) from Perform to Outperform and announces $4 pr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION